Avantor earnings date
Want to see AVTR full AI Analyst Report?
Avantor (AVTR) Q3 2026 Earnings Report
AVTR Q3 2026 EPS Results
- Actual EPS
- $0.22
- Consensus EPS
- $0.21
- Beat/Miss
- Beat by +$0.01
- One Year Ago EPS
- $0.22
AVTR Q3 2026 Revenue Results
- Actual Revenue
- $1.70B
- Expected Revenue
- $1.64B
- Beat/Miss
- Beat by +$55.37M
- YoY Revenue Growth
- +4.59%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 10/28/2026
- Time
- Before Open
- Conference Call
- Wednesday, October 28, 2026
Avantor's next earnings date is estimated for February 4, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
Q3 2026 Earnings Call Summary
The call was strongly constructive. Avantor reported a return to organic growth, outperformance in both revenue and adjusted EPS, positive performance in VWR and BMP, robust free cash flow, lower leverage, improved order trends, and raised full-year guidance. The main challenges were mix and inflationary margin pressure, foreign-exchange headwinds, BMP comparison effects, pricing that remains below inflation, and a lagging European market. Highlights significantly outweighed the lowlights.
For full year 2026, Avantor raised its organic revenue growth outlook to a range of 0.75 to 1.25%, with Q4 organic revenue growth implied at 2.5 to 4.5%; foreign exchange is expected to be a headwind of 150 basis points to reported revenue in Q4 and contribute approximately 75 basis points to full year reported revenue growth. VWR is expected to grow mid single digits in Q4, while BMP is expected to deliver year over year organic growth that is flat to slightly positive, reflecting approximately 400 basis points of headwind from discrete comparisons, with modest sequential growth from Q3 to Q4. Adjusted EBITDA margin guidance remains unchanged and is expected to expand modestly from Q3 to Q4; the adjusted effective tax rate is expected to be between 22% and 22.5%, weighted average diluted share count is expected to be 679 million shares, adjusted EPS guidance is $0.81 to $0.83, and free cash flow guidance is between $520 million and $550 million in 2026, with the adjusted net leverage ratio expected to be below 3x by year end.
- Return to Organic Revenue GrowthAvantor generated third-quarter revenue of $1.698 billion, representing 5.2% year-over-year organic growth and 4.6% reported growth, exceeding expectations. Management described the quarter as Avantor's return to organic revenue growth and an important milestone in the Revival program.
- VWR Growth AccelerationVWR organic revenue growth accelerated to 5.8% in the third quarter, driven by higher volumes, improving commercial execution, and stronger end markets. Approximately half of VWR's Q3 growth was attributed to commercial initiatives, including large-customer contract renewals, increased share of wallet, stronger performance with small and midsized customers, and ecommerce improvements.
- BMP Returned to Organic GrowthThe Bioscience and Medtech Products segment returned to growth, with organic revenue increasing 3.6% year over year, ahead of expectations despite a 150-basis-point headwind from unusual customer ordering and shipment patterns. Management said Revival initiatives are improving consistency and predictability across BMP.
- Strong Process Chemicals and NuSil PerformanceWithin BMP, process chemicals grew at a high-single-digit rate, driven by improving operations, healthy end-market conditions, and strong orders. NuSil grew at a low-teens rate, supported by effective execution against a healthy order book and strong order trends.
- Improved Profitability and Cash GenerationAdjusted EBITDA was $257 million, producing a 15.1% margin, while adjusted EPS was $0.22 and exceeded expectations. Adjusted EBITDA margin expanded sequentially as operational outperformance and expense discipline absorbed mix and inflationary pressures while supporting targeted growth investments.
- Robust Free Cash Flow and Balance-Sheet ProgressThird-quarter free cash flow was $156 million, or $169 million excluding cash restructuring costs. Avantor reduced net debt by $173 million to $3.235 billion and lowered its adjusted net leverage ratio to 3.1x from 3.3x in the prior quarter. Management expects to reduce adjusted net leverage below 3x by year end.
- Raised Full-Year 2026 GuidanceAvantor raised its full-year 2026 organic revenue growth outlook to 0.75% to 1.25%, adjusted EPS guidance to $0.81 to $0.83, and free cash flow guidance to $520 million to $550 million. The revised outlook reflects third-quarter outperformance and modestly higher fourth-quarter growth assumptions.
- Positive Fourth-Quarter Segment OutlookFourth-quarter organic revenue growth is expected to be 2.5% to 4.5%. VWR is expected to grow at a mid-single-digit rate, while BMP is expected to be flat to slightly positive organically and to deliver modest sequential growth from Q3. Management expects adjusted EBITDA margin to expand modestly from Q3 to Q4.
- Revival Execution ImprovementsManagement reported progress across Revival's commercial, operational, supply-chain, service-level, talent, and go-to-market priorities. Manufacturing throughput increased sequentially during 2026, customer onboarding was simplified, operating discipline and accountability strengthened, and production and service levels in BMP improved.
- Manufacturing Throughput MilestoneIn early September, a key North American manufacturing line produced more than 25,000 kilograms of product in a single week, exceeding its original design-capacity target and achieving nearly 99% overall equipment effectiveness for that week.
- Digital Manufacturing and Supply-Chain ProgressAvantor advanced its digital manufacturing strategy through digital workflows and electronic batch records at two key manufacturing sites. Management said these capabilities improve quality, reduce deviations, and enhance delivery performance. S&OP and other process-improvement initiatives were also contributing to better customer service and on-time delivery in certain product categories.
- AI and Ecommerce InvestmentsAvantor is deploying AI to improve productivity and customer experience, including the VWR internal sales assistant, which combines customer and product data to help sales teams prepare for meetings, generate leads, prioritize opportunities, and simplify administrative tasks. Management plans to expand the tool and add functionality. Avantor also relaunched vwr.com around the end of Q1 or early Q2, reported positive feedback, and plans to continue investing in ecommerce, AI-enabled product cross-referencing, supply chain, and digital capabilities.
- Improving End-Market ConditionsManagement said the recovery that began in Q2 continued and broadened in Q3. Large pharmaceutical and biotech customers continued investing in R&D pipelines, while higher education and early-stage biotech customers in North America showed early recovery signs. Certain industrial subsectors, including mining, were strong, and activity in Asia was described as good.
- Positive Order and Book-to-Bill TrendsBMP had healthy order trends across all business units, with particular strength in NuSil. Book-to-bill was positive for the third consecutive quarter, and process chemicals had high-single-digit year-to-date orders and high-single-digit sales performance. Management said BMP lead times remained approximately three to six months depending on the product line.
- Leadership Team CompletedTodd Garner joined as CFO on September 21, and Mikey Santiago was announced as the incoming chief information officer. Management said the executive leadership team is now complete and that approximately 65% of the broader N-minus-two leadership layer had been refreshed.
- Improved Pricing ExecutionManagement said pricing execution improved significantly versus the prior year through better governance, tools, visibility, and commercial discipline. Year-to-date pricing was described as between 1% and 2%, and the company said it had recovered costs more effectively than in the prior year.
- AI Viewed as an Industry TailwindManagement said AI-driven productivity improvements in pharmaceutical research and development could support increased research, development, and manufacturing activity, which Avantor serves through both VWR and BMP. AI was characterized as a potential tailwind for the business.
AVTR Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 04, 2027 | 2026 (Q4) | 0.22- | 0.22 | ― | ― |
| Oct 28, 2026 | 2026 (Q3) | 0.210.22 | 0.22 | 0.00% (+0.00) | |
| Jul 29, 2026 | 2026 (Q2) | 0.190.21 | 0.24 | -12.50% (-0.03) | |
| Apr 29, 2026 | 2026 (Q1) | 0.160.17 | 0.23 | -26.09% (-0.06) | |
| Feb 11, 2026 | 2025 (Q4) | 0.220.22 | 0.27 | -18.52% (-0.05) | |
| Oct 29, 2025 | 2025 (Q3) | 0.230.22 | 0.26 | -15.38% (-0.04) | |
| Aug 01, 2025 | 2025 (Q2) | 0.250.24 | 0.25 | -4.00% (-0.01) | |
| Apr 25, 2025 | 2025 (Q1) | 0.230.23 | 0.22 | 4.55% (+0.01) | |
| Feb 07, 2025 | 2024 (Q4) | 0.260.27 | 0.25 | 8.00% (+0.02) | |
| Oct 25, 2024 | 2024 (Q3) | 0.260.26 | 0.25 | 4.00% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.


